Repeated treatment protocols for melasma and acquired dermal melanocytosis

被引:27
作者
Yoshimura, K [1 ]
Sato, K [1 ]
Aiba-Kojma, E [1 ]
Matsumoto, D [1 ]
Machino, C [1 ]
Nagase, T [1 ]
Gonda, K [1 ]
Koshima, I [1 ]
机构
[1] Univ Tokyo, Sch Med, Dept Plast Surg, Bunkyo Ku, Tokyo 1138655, Japan
关键词
D O I
10.1111/j.1524-4725.2006.32074.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
BACKGROUND AND OBJECTIVE Melasma and acquired dermal melanocytosis (ADM; acquired bilateral nevus of Ota-like macules) are both seen most commonly symmetrically on the face of women with darker skin and are also known as difficult conditions to treat. METHODS Our topical bleaching protocol with 0.1 to 0.4% tretinoin gel and 5% hydroquinone was performed repeatedly (1-3 times) for melasma (n=163), and a combination treatment with topical bleaching and Q-switched ruby (QSR) laser was performed repeatedly (1-3 times) for ADM (n = 62). RESULTS There is a significant correlation between clinical results (clearance of pigmentation) and the number of sessions in both melasma (p=.019) and ADM (p <.0001). CONCLUSION The repeated treatment protocol for melasma and ADM showed successful clinical results compared with conventional ones, and they may be applied to other pigment conditions. It may be better that epidermal and dermal pigmentations are treated separately, especially in dark-skinned people who are more likely to suffer postinflammatory hyperpigmentation after inflammation-inducing therapies.
引用
收藏
页码:365 / 371
页数:7
相关论文
共 15 条
[1]
The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions [J].
Garcia, A ;
Fulton, JE .
DERMATOLOGIC SURGERY, 1996, 22 (05) :443-447
[2]
TOPICAL TRETINOIN (RETINOIC ACID) IMPROVES MELASMA - A VEHICLE-CONTROLLED, CLINICAL-TRIAL [J].
GRIFFITHS, CEM ;
FINKEL, LJ ;
DITRE, CM ;
HAMILTON, TA ;
ELLIS, CN ;
VOORHEES, JJ .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (04) :415-421
[3]
MELASMA - ETIOLOGIC AND THERAPEUTIC CONSIDERATIONS [J].
GRIMES, PE .
ARCHIVES OF DERMATOLOGY, 1995, 131 (12) :1453-1457
[4]
ACQUIRED, BILATERAL NEVUS OF OTA-LIKE MACULES [J].
HORI, Y ;
KAWASHIMA, M ;
OOHARA, K ;
KUKITA, A .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1984, 10 (06) :961-964
[5]
Efficacy of glycolic acid peels in the treatment of melasma [J].
Hurley, ME ;
Guevara, IL ;
Gonzales, RM ;
Pandya, AG .
ARCHIVES OF DERMATOLOGY, 2002, 138 (12) :1578-1582
[6]
Treatment of melasma with Jessner's solution versus glycolic acid: A comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination [J].
Lawrence, N ;
Cox, SE ;
Brody, HJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (04) :589-593
[7]
Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for acquired dermal melanocytosis [J].
Momosawa, A ;
Yoshimura, K ;
Uchida, G ;
Sato, K ;
Aiba, E ;
Matsumoto, D ;
Yamaoka, H ;
Mihara, S ;
Tsukamoto, K ;
Harii, K ;
Aoyama, T ;
Iga, T .
DERMATOLOGIC SURGERY, 2003, 29 (10) :1001-1007
[8]
MUINDI J, 1992, BLOOD, V79, P299
[9]
Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma [J].
Nanda, S ;
Grover, C ;
Reddy, BSN .
DERMATOLOGIC SURGERY, 2004, 30 (03) :385-389
[10]
Clinical pharmacokinetics of tretinoin [J].
Regazzi, MB ;
Iacona, I ;
Gervasutti, C ;
Lazzarino, M ;
Toma, S .
CLINICAL PHARMACOKINETICS, 1997, 32 (05) :382-402